1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. MAZE THERAPEUTICS INC.
Maze Therapeutics Inc. XNAS: MAZE
43.58 -1.42 (-3.16%)
486.8K
XNAS Volume

XNAS 30 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for Maze Therapeutics Inc is on 04 Feb 2026 for the purpose of Maze Therapeutics Inc Annual General Meeting for 2025 See details

Maze Therapeutics Inc - MAZE - stock price prediction, stock price target, analyst ratings from 10 analysts

Maze Therapeutics Inc has a share price target of US$ 49, revenue growth forecast of -99.2%, and profit growth estimate of -3929.9% for FY26, based on top 10 analyst calls.